Text Version
Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM
Gateway
TOXNET
Consumer
Health
Clinical Alerts
ClinicalTrials.gov
PubMed
Central
Privacy Policy
|
 |
-
Fluoxetine dose-increment related
akathisia in depression: implications for clinical care, recognition and
management of selective serotonin reuptake inhibitor-induced
akathisia.
Hansen L.
Department of
Psychiatry, Royal South Hants, Southampton, UK.
lh4@soton.ac.uk
We report the case of a 22-year-old woman
presenting major depressive episode with severe akathisia after an
increase in fluoxetine. The patient developed severe restlessness and de
novo suicidal ideation approximately 1 week after the dosage of
fluoxetine was doubled, 1 year on from when the drug was first
introduced. This case illustrates the importance of being alert to
movement disorders in patients treated with selective serotonin reuptake
inhibitors. The clinical implications are discussed. A management
strategy based on the evidence in the existing literature is
suggested.
PMID: 14870959 [PubMed - in process]
|